{
  "docId": "019de514-833c-7520-a4a9-200b68fbb681",
  "docSlug": "d869e39fe11534a9d64784c9e4f475f2",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 47 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 47,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "kpi_overview",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 23,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de514-833c-7520-a4a9-200b68fbb681/9",
  "deckHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681",
  "deckJsonHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681.json",
  "deckAnchorHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.34,
        "w": 0.25,
        "x": 0.06,
        "y": 0.22
      },
      "kind": "chart",
      "text": "Total Company Revenue Millions USD 949 942 3Q21 3Q22",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cdcfd13d-7673-4026-a27e-f11d56cd6137",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.19,
        "x": 0.56,
        "y": 0.17
      },
      "kind": "chart",
      "text": "Surgical $172M 54% 27% 19% Implantables Equipment Consumables/Other",
      "attrs": null,
      "subkind": "donut",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5f772da7-0a47-466e-86eb-c2340e8cbda9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.19,
        "x": 0.35,
        "y": 0.17
      },
      "kind": "chart",
      "text": "Vision Care $598M 63% 37% Contact Lens Consumer",
      "attrs": null,
      "subkind": "donut",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b4836a6b-2778-428b-b75a-5d897b7705b3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.19,
        "x": 0.77,
        "y": 0.17
      },
      "kind": "chart",
      "text": "Ophthalmic Pharmaceuticals $172M 39% 61% U.S. International",
      "attrs": null,
      "subkind": "donut",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc98e3f9-45b8-40b2-94b6-298b3917da5a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.19,
        "x": 0.35,
        "y": 0.61
      },
      "kind": "list",
      "text": "+4% Strong demand for key franchises: Lumify® (+7% reported revenue growth) Ocuvite® + PreserVision® (+14% reported revenue growth) Daily SiHy (+8% reported revenue growth) Bausch + Lomb ULTRA® (+7% reported revenue growth) BioTrue ONEday® (+2% reported revenue growth)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "037e2d64-608c-4742-9ebe-86108101314e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.27,
        "w": 0.19,
        "x": 0.56,
        "y": 0.61
      },
      "kind": "list",
      "text": "+8% Growth in implantables (+4% reported revenue growth; +14% organic revenue growth1,2), driven by premium and standard IOLs Strong demand for consumables (-2% reported revenue decline; +6% organic revenue growth1,2), driven by increase in cataract and retina procedures",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f7fc98f-a387-490e-aff9-01017af6825a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.27,
        "w": 0.28,
        "x": 0.05,
        "y": 0.61
      },
      "kind": "list",
      "text": "+5% organic revenue1,2 growth Sixth consecutive quarter of organic revenue growth COVID recovery progressing in China Recession resilient portfolio, able to absorb slower consumer activity and continue growth",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "47057263-dcb5-48ec-a899-4efb7037d47c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.19,
        "x": 0.77,
        "y": 0.61
      },
      "kind": "list",
      "text": "+5% Strong performance in international portfolio (+3% reported revenue growth; +15% organic revenue growth1,2) Vyzulta® saw 29% TRx growth3 in 3Q22 Positive early stages of XIPERE® launch",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d36c9efb-ad51-4551-bd24-bff818802c8f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.66,
        "x": 0.15,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "1. This is a non-GAAP measure or ratio. See Slide 2 and Appendix for further information on non-GAAP measures and ratios. 2. Organic revenue growth/change, a non-GAAP ratio, is defined as a change on a period-over-period basis in revenues on a constant currency basis (if applicable) excluding the impact of acquisitions, divestitures and discontinuations. 3. IQVIA NPA monthly. U.S. only.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "804ed900-b129-4692-83b4-fe3aaadbdaa7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.899,
        "x": 0.059,
        "y": 0.039
      },
      "kind": "title",
      "text": "3Q22 Financial Highlights & Segment Drivers Organic Revenue Growth1,2 in All Three Segments Despite Inflation and FX Headwinds",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8d14d2af-7cd0-4394-b68f-70c53183f9c3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Waterfall chart",
      "slug": "waterfall-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "96275ecc-12ad-4811-a48e-1c4f7d285fbf",
      "evidence": "chart/waterfall: +5% organic revenue growth1,2 $949M +$48M -$55M $942M 3Q21 Revenue Business Performance FX Impact 3Q22 Revenue",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 9,
      "from": 6,
      "beatId": "a56f4739-afad-4b91-b821-f4c821080ec5",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The deck highlights the company's standalone opportunity and 3Q22 financial highlights.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 8,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "2db31f9e-b83f-42ae-bc1e-3fdb56dcace3",
      "evidence": "The deck highlights organic revenue growth in all three segments.",
      "position": 0,
      "objective": "To identify patterns in Bausch + Lomb's revenue growth",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.6,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}